Skip to main content
. 2019 Aug 8;14(8):e0220860. doi: 10.1371/journal.pone.0220860

Fig 4. CD133 knockout inhibits cell migration and invasion.

Fig 4

(A) Photographs at 0 and 24h after wounding demonstrated that CRISPR-Cas9 mediated CD133knockout cells showed significantly decreased wound healing rate compared to the control (***P<0.001). (B) CD133knockout cells had the least average number of migrating cells among the three groups in transwell migration assay (***P<0.001). (C) In transwell invasion assay, the average number of invasive cells in CD133knockout group was 11.67 and control cells were 32.33 and 29.67, respectively (***P<0.001).